$200,000 / 2 years – Awarded 2024
The Walter and Eliza Hall Institute of Medical Research (WEHI)
Parkville, Australia
About
Professor Ethan D. Goddard-Borger is a leading scientist in drug discovery and chemical biology, with extensive experience in developing small-molecule inhibitors against challenging therapeutic targets. His expertise in enzyme biochemistry, glycobiology, and structural biology, combined with his passion for developing new contraceptive options makes him ideally positioned to lead this innovative project.
Our Grant
Male Contraceptive Initiative is thrilled to support Professor Goddard-Borger’s research on DPY19L2 as a target for male contraception. This project aligns with our mission to fund cutting-edge research that can lead to safe, effective, and reversible contraceptive options for men.